-+ 0.00%
-+ 0.00%
-+ 0.00%

Arcutis appoints Mirum CEO Chris Peetz to board

PUBT·07/16/2026 13:03:41
Listen to the news
Arcutis appoints Mirum CEO Chris Peetz to board
  • Arcutis appointed Christopher “Chris” Peetz to its board, effective July 15, 2026.
  • Peetz is co-founder, chief executive officer of Mirum Pharmaceuticals; entrepreneur-in-residence at Frazier Life Sciences.
  • He previously led Flashlight Therapeutics as CEO; served as CFO, head of corporate development at Tobira before its sale to Allergan.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcutis Biotherapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607160900PRIMZONEFULLFEED9763386) on July 16, 2026, and is solely responsible for the information contained therein.